NCT02377336View on ClinicalTrials.gov

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Ischemic Heart Disease
Interventions
DRUG

GS-6615

GS-6615 tablets administered orally

DRUG

Placebo

Placebo to match GS-6615 tablets administered orally

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY